DE PONTI, FABRIZIO
Dettaglio
DE PONTI, FABRIZIO
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di Ia fascia
Pubblicazioni
Risultati 1 - 20 di 202 (tempo di esecuzione: 0.001 secondi).
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
---|---|---|---|---|---|---|---|
1 | 5-HT7 receptors are involved in the accommodation of the circular muscle during peristalsis in the guinea-pig ileum | VICINI R.; CERVIO E.; AGAZZI A.; DE GIORGIO R.; BARBARA G.; DE PONTI F.; TONINI M. | 2004 | DIGESTIVE AND LIVER DISEASE | 4.02 Riassunto (Abstract) | - | |
2 | 5-HT7 Receptors Modulate Peristalsis and Accommodation in the Guinea Pig Ileum | Marcello, Tonini; Riccardo, Vicini; Elisabetta, Cervio; Fabrizio, De Ponti; Roberto, De Giorgio; ...Giovanni, Barbara; Vincenzo, Stanghellini; Antonio, Dellabianca; Catia, Sternini | 2005 | GASTROENTEROLOGY | 1.01 Articolo in rivista | - | |
3 | Abnormalities of human gallbladder muscle associated with inflammation: an in vitro study | MASELLI M.A.; TRISOLINI P.; PIEPOLI A.L.; MONTANARO S.; CARUSO M.L.; D’ATTOMA B.; PEZZOLLA F.; DE... PONTI F. | 2005 | Minerva Medica | 4.02 Riassunto (Abstract) | - | |
4 | Academic output from EU-funded health research projects | Mariam Molokhia;Fabrizio De Ponti;Elijah R Behr;Gianluca Trifirò;Miriam Sturkenboom | 2012 | THE LANCET | 1.04 Replica / breve intervento (e simili) | - | |
5 | Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis | Salvo, Francesco; Moore, Nicholas; Arnaud, Mickael; Robinson, Philip; Raschi, Emanuel; De Ponti, ...Fabrizio; Bégaud, Bernard; Pariente, Antoine | 2016 | BMJ BRITISH MEDICAL JOURNAL | 1.01 Articolo in rivista | - | |
6 | Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage | Poluzzi E.; Strahinja P.; Vaccheri A.; Vargiu A.; Silvani M.C.; Motola D.; Marchesini G.; De Pont...i F.; Montanaro N. | 2007 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1.01 Articolo in rivista | - | |
7 | Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. | Poluzzi E; Strahinja P; Vargiu A; Silvani MC; Motola D; Vaccheri A; De Ponti F; Marchesini Reggia...ni G; Montanaro N. | 2006 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 4.02 Riassunto (Abstract) | - | |
8 | Advancements in drug development for diarrhea-predominant irritable bowel syndrome | Dothel, Giovanni; Barbaro, Maria Raffaella; Raschi, Emanuel; Barbara, Giovanni; De Ponti, Fabrizio* | 2018 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | 1.01 Articolo in rivista | - | |
9 | Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies | Roberto, G; Raschi, E.; Piccinni, C.; Conti, V.; Vignatelli, L.; D'Alessandro, R.; De Ponti, F.; ...Poluzzi, E. | 2015 | CEPHALALGIA | 1.01 Articolo in rivista | - | |
10 | Adverse events associated with the use of direct-acting oral anticoagulants in clinical practice: beyond bleeding complications | Raschi, Emanuel; Bianchin, Matteo; Ageno, Walter; De Ponti, Roberto; De Ponti, Fabrizio | 2016 | POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ | 1.01 Articolo in rivista | - | |
11 | Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems | Raschi, Emanuel*; Girardi, Anna; Poluzzi, Elisabetta; Forcesi, Emanuele; Menniti-Ippolito, France...sca; Mazzanti, Gabriela; De Ponti, Fabrizio | 2018 | DRUG SAFETY | 1.01 Articolo in rivista | - | |
12 | Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system | Gatti M.; Antonazzo I.C.; Diemberger I.; De Ponti F.; Raschi E. | 2020 | EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 1.01 Articolo in rivista | - | |
13 | Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems | Raschi, E.; Parisotto, M.; Forcesi, E.; La Placa, M.; Marchesini, G.; De Ponti, F.; Poluzzi, E. | 2017 | NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES | 1.01 Articolo in rivista | - | |
14 | Advising Mothers on the Use of Medications during Breastfeeding : A Need for a Positive Attitude | Davanzo, Riccardo; Bua, Jenny; De Cunto, Angela; Farina, Maria Luisa; De Ponti, Fabrizio; Clavenn...a, Antonio; Mandrella, Stefania; Sagone, Antonella; Clementi, Maurizio | 2016 | JOURNAL OF HUMAN LACTATION | 1.01 Articolo in rivista | - | |
15 | Altered Serotonin Signaling and Extrinsic Sensory Neuron Activation in Irritable Bowel Syndrome | C. Cremon; G. Carini; G. Dothel; V. Vasina; R. De Giorgio; V. Stanghellini; F. De Ponti; M. Tonin...i; D. Grundy; R. Corinaldesi; G. Barbara | 2010 | GASTROENTEROLOGY | 4.02 Riassunto (Abstract) | - | |
16 | Animal models of chemically induced intestinal inflammation: Predictivity and ethical issues | Giovanni Dothel; Valentina Vasina; Giovanni Barbara; Fabrizio De Ponti | 2013 | PHARMACOLOGY & THERAPEUTICS | 1.01 Articolo in rivista | - | |
17 | Antibacterial macrolides: a drug class with a complex pharmacological profile | ABU-GHARBIEH E.; VASINA V.; POLUZZI E.; DE PONTI F. | 2004 | PHARMACOLOGICAL RESEARCH | 1.01 Articolo in rivista | - | |
18 | Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. | Raschi, E; Vasina, V; Ursino, M G; Boriani, G; Martoni, A; De Ponti, F | 2010 | PHARMACOLOGY & THERAPEUTICS | 1.01 Articolo in rivista | - | |
19 | Antimicrobial-induced torsades de pointes: towards risk stratification by data mining of the FDA Adverse Event Reporting System. | E. Poluzzi; E. Raschi; D. Motola; U. Moretti; F. De Ponti | 2009 | BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 1.01 Articolo in rivista | - | |
20 | Antimicrobials and the Risk of Torsades de Pointes. The Contribution from Data Mining of the US FDA Adverse Event Reporting System | E. Poluzzi; E. Raschi; D. Motola; U. Moretti; F. De Ponti | 2010 | DRUG SAFETY | 1.01 Articolo in rivista | - |